CONE · Cyrusone Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 | Q4 '20 | Q3 '20 | Q2 '20 | Q1 '20 | Q4 '19 | Q3 '19 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | $304.10M | $284.60M | $298.60M | - | $262.80M | $256.40M | $245.90M | - | $250.90M |
| Cost of Revenue | - | $133.40M | $121.80M | $135.80M | - | $109.70M | $99.00M | $92.60M | - | $103.00M |
| Gross Profit | - | $170.70M | $162.80M | $162.80M | - | $153.10M | $157.40M | $153.30M | - | $147.90M |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | - | $30.80M | $16.60M | $23.00M | - | $29.70M | $20.30M | $26.90M | - | $19.80M |
| Total Operating Expenses | - | $295.60M | $266.00M | $284.60M | - | $267.40M | $235.30M | $232.70M | - | $237.70M |
| D&A | - | $127.50M | $123.70M | $121.40M | - | $113.10M | $109.70M | $108.10M | - | $105.40M |
| Operating Income | - | $8.50M | $18.60M | $14.00M | - | ($4.60M) | $21.10M | $13.20M | - | $13.20M |
| Interest Expense | - | $17.30M | $14.80M | $15.10M | - | $13.30M | $13.90M | $16.00M | - | $19.60M |
| Income Tax | - | ($1.00M) | ($2.30M) | ($1.60M) | - | ($1.90M) | ($1.20M) | ($1.20M) | - | ($2.00M) |
| Net Income | - | $6.70M | $7.40M | $18.20M | - | ($37.30M) | $45.00M | $14.70M | - | $12.60M |
| EPS - Basic | - | $0.05 | $0.06 | $0.15 | - | ($0.32) | $0.39 | $0.13 | - | $0.11 |
| EPS - Diluted | - | $0.05 | $0.06 | $0.15 | - | ($0.32) | $0.39 | $0.13 | - | $0.11 |
Balance Sheet
| Line item | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 | Q4 '20 | Q3 '20 | Q2 '20 | Q1 '20 | Q4 '19 | Q3 '19 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $346.30M | $456.40M | $369.70M | $240.90M | $271.40M | $156.50M | $70.70M | $57.30M | $76.40M | $51.70M |
| Accounts Receivable | - | - | - | - | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | - | - | - | - | - | - | - | - | - | - |
| Current Assets | - | - | - | - | - | - | - | - | - | - |
| Total Assets | $7.45B | $7.34B | $7.24B | $6.91B | $6.90B | $6.71B | $6.47B | $6.28B | $6.14B | $5.89B |
| Current Liabilities | - | - | - | - | - | - | - | - | - | - |
| Long-term Debt | $3.49B | $3.52B | $3.54B | $3.34B | $3.41B | $3.20B | $3.16B | $3.05B | $2.89B | $2.78B |
| Total Liabilities | $4.53B | $4.53B | $4.58B | $4.30B | $4.34B | $4.11B | $4.01B | $3.91B | $3.71B | $3.48B |
| Stockholders' Equity | $2.92B | $2.81B | $2.66B | $2.61B | $2.56B | $2.60B | $2.46B | $2.36B | $2.43B | $2.42B |
| Retained Earnings | ($1.20B) | ($1.13B) | ($1.07B) | ($1.01B) | ($966.60M) | ($923.90M) | ($824.70M) | ($811.00M) | ($767.30M) | ($657.40M) |
Cash Flow
| Line item | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 | Q4 '20 | Q3 '20 | Q2 '20 | Q1 '20 | Q4 '19 | Q3 '19 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | $106.70M | - | - | - | $86.30M | - | - |
| Investing Cash Flow | - | - | - | ($124.40M) | - | - | - | ($199.80M) | - | - |
| Financing Cash Flow | - | - | - | ($10.70M) | - | - | - | $93.50M | - | - |
| CapEx | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 | Q4 '20 | Q3 '20 | Q2 '20 | Q1 '20 | Q4 '19 | Q3 '19 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | 56.1% | 57.2% | 54.5% | - | 58.3% | 61.4% | 62.3% | - | 58.9% |
| Operating margin | - | 2.8% | 6.5% | 4.7% | - | -1.8% | 8.2% | 5.4% | - | 5.3% |
| EBITDA margin | - | 44.7% | 50.0% | 45.3% | - | 41.3% | 51.0% | 49.3% | - | 47.3% |
| Net margin | - | 2.2% | 2.6% | 6.1% | - | -14.2% | 17.6% | 6.0% | - | 5.0% |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | 10.1% | 5.8% | 7.7% | - | 11.3% | 7.9% | 10.9% | - | 7.9% |
| Effective tax rate | - | -17.5% | -45.1% | -9.6% | - | - | -2.7% | -8.9% | - | -18.9% |
| Return on assets | - | 0.1% | 0.1% | 0.3% | - | -0.6% | 0.7% | 0.2% | - | 0.2% |
| Return on equity | - | 0.2% | 0.3% | 0.7% | - | -1.4% | 1.8% | 0.6% | - | 0.5% |
| Return on invested capital | - | 0.1% | 0.3% | 0.2% | - | -0.1% | 0.4% | 0.2% | - | 0.3% |
| Liquidity | ||||||||||
| Current ratio | - | - | - | - | - | - | - | - | - | - |
| Quick ratio | - | - | - | - | - | - | - | - | - | - |
| Cash ratio | - | - | - | - | - | - | - | - | - | - |
| Leverage | ||||||||||
| Debt / Equity | 1.19 | 1.25 | 1.33 | 1.28 | 1.33 | 1.23 | 1.28 | 1.29 | 1.19 | 1.15 |
| Debt / Assets | 0.47 | 0.48 | 0.49 | 0.48 | 0.49 | 0.48 | 0.49 | 0.49 | 0.47 | 0.47 |
| Debt / EBITDA | - | 25.85 | 24.89 | 24.65 | - | 29.47 | 24.14 | 25.12 | - | 23.41 |
| Interest coverage | - | 0.5x | 1.3x | 0.9x | - | -0.3x | 1.5x | 0.8x | - | 0.7x |
| Equity multiplier | 2.55 | 2.62 | 2.73 | 2.64 | 2.70 | 2.58 | 2.63 | 2.66 | 2.52 | 2.44 |
| Liabilities / Assets | 0.61 | 0.62 | 0.63 | 0.62 | 0.63 | 0.61 | 0.62 | 0.62 | 0.60 | 0.59 |
| Efficiency | ||||||||||
| Asset turnover | - | 0.04 | 0.04 | 0.04 | - | 0.04 | 0.04 | 0.04 | - | 0.04 |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | - | 15.7% | 11.0% | 21.4% | - | 4.7% | 1.9% | 9.3% | - | 21.4% |
| Revenue CAGR (3y) | - | 13.8% | 13.1% | 14.9% | - | 14.4% | 15.4% | 18.1% | - | 20.4% |
| Revenue CAGR (5y) | - | 16.2% | 16.9% | 20.4% | - | 18.8% | 23.5% | 23.5% | - | - |
| Gross profit growth (YoY) | - | 11.5% | 3.4% | 6.2% | - | 3.5% | 6.2% | -2.5% | - | 14.7% |
| Operating income growth (YoY) | - | - | -11.8% | 6.1% | - | - | 7.1% | 11.9% | - | -34.7% |
| Net income growth (YoY) | - | - | -83.6% | 23.8% | - | - | - | -83.6% | - | - |
| EPS growth (YoY) | - | - | -84.6% | 15.4% | - | - | - | -84.1% | - | - |
| EPS CAGR (3y) | - | - | -61.6% | - | - | - | - | - | - | 30.1% |
| EPS CAGR (5y) | - | 0.0% | -11.4% | 16.5% | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 14.3% | 7.7% | 8.0% | 10.6% | 5.1% | 7.8% | -0.1% | -0.6% | 9.4% | 7.9% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2021-12-31.
Product / service
$2.43B totalLease Revenue$1.18B · 48.8%
Colocation Lease Revenue$924.10M · 38.1%
Tenant Reimbursements$259.00M · 10.7%
Other Customer Contract Revenue$22.60M · 0.9%
Other Services$18.40M · 0.8%
Contracts With Customers$15.10M · 0.6%
Equipment Sales$4.20M · 0.2%
Geographic
$400.0K totalNon Us$400.0K · 100.0%
Peer comparison
Same SIC group: Real Estate Investment Trusts
Comparing CyrusOne Inc. against the 5 most active filers in the same SIC group.